文献
J-GLOBAL ID:201702245624172532
整理番号:17A0063170
CD20陽性古典ホジキンリンパ腫の臨床的特徴と予後分析【JST・京大機械翻訳】
Clinical features and prognosis of CD20-positive classical Hodgkin lymphoma
著者 (10件):
Qin Yan
(Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College)
,
Kang Suyi
(Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College)
,
He Xiaohui
(Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College)
,
Zhou Shengyu
(Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College)
,
Liu Peng
(Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College)
,
Yang Jianliang
(Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College)
,
Zhang Changgong
(Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College)
,
Yang Sheng
(Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College)
,
Gui Lin
(Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College)
,
Shi Yuankai
(Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College)
資料名:
Zhonghua Yixue Zazhi
(Zhonghua Yixue Zazhi)
巻:
96
号:
28
ページ:
2224-2228
発行年:
2016年
JST資料番号:
C2298A
ISSN:
0376-2491
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
中国 (CHN)
言語:
中国語 (ZH)